Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-26

FDA Approved: MEXILETINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original Abbreviated New Drug Application for mexiletine hydrochloride by Rising Pharma Holdings, making a generic antiarrhythmic available for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mexiletine hydrochloride (mexiletine hydrochloride)

Snippet

ORIG AP for MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE)